Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

News

 

GHP rolls out new deal with insurers

GHP, the Stockholm-listed Swedish and Middle East clinic chain, where shares have risen all but sevenfold in seven years, is rolling out a new outsourced model for health insurers. So far this covers 100,000 patients. We talk to CEO Daniel Ohman.

Advent rekindles Dentix bid

Advent, the owner of Spain's largest dentistry group Vitaldent, has emerged as the leading bidder for the market's second player, Dentix, despite earlier reports that it had frozen a rescue package.

Helios eats pack of Maltesers

German and Spanish hospital group Fresenius Helios is buying three more hospitals in Germany from the Malteser non-profit foundation, adding €160m in annual sales and increasing size of the for-profit hospital sector by 1-1.5%.

Rede d’Or hires banks for $2.7bn IPO

Rede d'Or, Brazil's largest hospital chain by revenue, has reportedly hired banks to prepare a long-awaited $2.7bn IPO for the autumn. The company reportedly expects a valuation of $17.8bn, which would make it the second-largest listed hospital group in the world by market capitalisation after HCA.

Sonic Healthcare ‘reviewing its Irish operations’

Global lab company Sonic Healthcare is reportedly reviewing its Irish operations as litigation claims related to Ireland’s CervicalCheck scandal mount and the subsidiary posts falling profits. HBI examines the role of the private sector in the screening scandal and talks to a solicitor representing half of the plaintiffs. Documents seen by HBI show evidence that slides were up to 7x more likely to be misread when outsourced.

BGI profits rocket but blacklisting could threaten supply chain

Profits at lab group Bejing Genomics Institute (BGI) are up 734% in the first half of the year after the company rapidly built 58 labs in 18 countries and sold 35m testing kits to 92% of the countries in the world for COVID-19. Yet the company is now caught up in the ever-escalating US-China trade war as two subsidiaries have been blacklisted by the States. HBI examines what this means for its global reach.

Investors discuss opportunities in Nigeria’s private healthcare sector

A panel of Nigeria's healthcare operators, private equity investors and finance institutions including the IFC discussed opportunities for financing the sector in a recent panel discussion. HBI asked one of them whether recent entries into the diagnostics space from foreign entities are a benefit or are just helping to cream off the top-tier of the market.

France’s regional hospital groups consolidate as multiples increase

France's regional for-profit hospital operators have spent the last 12 months aggressively consolidating the c.65% of the sector not held by Ramsay Sante and Elsan who have been notably quiet on home turf. Vivalto, C2S and Doctegestio have added a collective €500m in sales while the larger pair have done as much selling as buying. Why? HBI talks to a Paris-based M&A advisor, who says deal pricing has improved as shown by the recent Elsan deal.

Coronaria CEO: no plan to sell optical retail unit after ophtha merger

Finland’s fourth-largest healthcare operator, Coronaria, has built the biggest ophthalmology business in Finland and is also the largest player in rehabilitation. We talk to CEO Teppo Lindén about his plans, why he is keeping the optician arm and the impact of Covid.

Bergman to re-launch sale process

Dutch and Nordic ambulatory and ophthalmology clinic chain Bergman Clinics will soon be back on the market after COVID delayed a process which began earlier this year, multiple sources tell HBI. We look at the facts and figures behind the prospective sale, and speculate on multiple and price. We are told it targeted the rest of Capio Germany from Ramsay Sante before the pandemic.

Find Us